Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Czechia
2 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in CzechiaStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Prague
- Age
- 6 years and over
- People
- 26 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - Phase 2/3Taking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Prague
- Age
- 18 years to 85 years
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00